DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Firebrick Pharma (ASX:FRE) founder and CEO Peter Molloy addressed investors this week around commercialisation of Nasodine, a nasal spray that kills cold and flu viruses without any potential for ...